Galota, F.; Marcheselli, S.; De Biasi, S.; Gibellini, L.; Vitetta, F.; Fiore, A.; Smolik, K.; De Napoli, G.; Cardi, M.; Cossarizza, A.;
et al. Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells. Cells 2025, 14, 606.
https://doi.org/10.3390/cells14080606
AMA Style
Galota F, Marcheselli S, De Biasi S, Gibellini L, Vitetta F, Fiore A, Smolik K, De Napoli G, Cardi M, Cossarizza A,
et al. Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells. Cells. 2025; 14(8):606.
https://doi.org/10.3390/cells14080606
Chicago/Turabian Style
Galota, Federica, Simone Marcheselli, Sara De Biasi, Lara Gibellini, Francesca Vitetta, Alessia Fiore, Krzysztof Smolik, Giulia De Napoli, Martina Cardi, Andrea Cossarizza,
and et al. 2025. "Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells" Cells 14, no. 8: 606.
https://doi.org/10.3390/cells14080606
APA Style
Galota, F., Marcheselli, S., De Biasi, S., Gibellini, L., Vitetta, F., Fiore, A., Smolik, K., De Napoli, G., Cardi, M., Cossarizza, A., & Ferraro, D.
(2025). Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells. Cells, 14(8), 606.
https://doi.org/10.3390/cells14080606